Association of Breast Reconstruction Method With Long-term Risk of Psychiatric Disorders
1 other identifier
observational
24,930
0 countries
N/A
Brief Summary
Female breast cancer patients who underwent total mastectomy followed by breast reconstruction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
April 23, 2025
CompletedFirst Posted
Study publicly available on registry
May 21, 2025
CompletedMay 21, 2025
May 1, 2025
9 years
April 23, 2025
May 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychiatric disorders
The primary endpoint was clinically diagnosed psychiatric disorder, defined as the first occurrence of a diagnosis made by a physician for any of the following major psychiatric conditions: anxiety disorders (F40, F41), bipolar disorder (F30, F31, F34.0), depressive disorders (F32, F33), sleep disorders (G47.0, F51.0), obsessive-compulsive disorder (F42), posttraumatic stress disorder (F43.1), and substance use disorders (F10-F19).
1 year, 5 year and 9 year since surgery
Study Arms (2)
autologous reconstruction
autologous reconstruction following mastectomy
implant-based reconstruction
implant-based reconstruction following mastectomy
Eligibility Criteria
The study included newly diagnosed female breast cancer patients who underwent total mastectomy followed by breast reconstruction classified into two types using ICD-10 procedure codes: autologous tissue reconstructions were coded from N7140 to N7147 and implant-based reconstructions were coded from N7148 to N7151 Exclusions applied to males, individuals who underwent reconstruction prior to mastectomy, and those diagnosed with psychiatric disorders within one year prior to surgery
You may qualify if:
- The study included newly diagnosed female breast cancer patients who underwent total mastectomy
You may not qualify if:
- individuals who underwent reconstruction prior to mastectomy
- those diagnosed with psychiatric disorders within one year prior to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 23, 2025
First Posted
May 21, 2025
Study Start
January 1, 2015
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share